ProAssurance Acquisition Enters Final Stages as Key Milestones Are Met

The planned acquisition of specialty insurer ProAssurance by The Doctors Company is advancing into its concluding phase, setting the stage for a fundamental transformation of the company. This analysis covers the definitive merger timeline, recent financial performance, and notable shifts in institutional investor holdings as the deal progresses.

Significant regulatory and shareholder approvals have now been secured for this cash transaction, valued at $25 per share. Shareholders demonstrated overwhelming support in June 2025, with Read more...